“Denver Health had been interested in electronic hand hygiene monitoring for some time,” said Heather Young, medical director of infection prevention at Denver Health Medical Center.
A newly published study by researchers from the CU School of Medicine has identified a potential therapeutic target for treating obesity and type 2 diabetes.
“What it does is it lowers the temperature of the scalp so that the fair follicles don’t see the chemotherapy and by that happening the hair does not fall out at all or at least not to the same degree that it would have,” said Virginia Borges.
“This technology is what they term an ingestible sensor,” said David Wyles, a physician at Denver Health Medical Center Infectious Disease. “And then we can look online and see exactly when the patient took their pills.”
“I just want care to change so badly,” Lilia Cervantes, a physician at Denver Health who is involved in Lucia’s care, said as she started to cry. “I can do all the research, but it’s not until people actually listen ... [that] access can finally change.”
Robert H. Eckel, professor at the CU School of Medicine, Anschutz Medical Campus: “The program that I envision is a 2-year internal medicine residency program, then a 4-year training program in metabolic diseases and cardiovascular disease prevention.”
“This study clarifies the need to develop targeted therapies with brain penetration against these oncogene-addicted lung cancers,” said Tejas Patil, oncology fellow at University of Colorado Cancer Center and instructor at CU School of Medicine.
Liquid biopsy and its subsequent molecular analysis is a powerful tool that can determine the patient’s molecular tumor profile in order to determine the best therapeutic option.
Deborah Rinehart, researcher at Denver Health, a public hospital affiliated with the CU School of Medicine, is studying a similar approach.
Research shows that doctors on the payrolls of drug or medical device companies are likely to prescribe that company’s product -- even if it’s not the best option for the patient, says Eric G. Campbell.
“It is not uncommon for patients on EOHD [emergency-only hemodialysis] to report frequent near-death experiences because of this requirement,” wrote lead author Lilia Cervantes.
“The PCRC [Palliative Care Research Cooperative Group] has developed key resources and infrastructure that are facilitating conduct of high quality palliative care research and fostering an interdisciplinary community of investigators,” said Jean Kutner
“The low rate of percutaneous coronary intervention suggests that many of the cardiac catheterizations may not have been clinically necessary,” wrote Ryan T. Borne, and Pamela N. Peterson.
Doctors are in the middle of a turnabout, said Matthew Wynia, director of the Center for Bioethics and Humanities at the CU Anschutz Medical Campus.
“The number 1 fact that we all have to contend with when we’re thinking about cardiovascular disease and diabetes is shortened life expectancy,” said Jane E.B. Reusch.